Vincrinak 2mg Injection
Marketer
Nakularch Meditech Pvt. Ltd.
Salt Composition
Vincristine (2mg)
Overview Vincrinak 2mg Injection
Oncaspar 2mg Injection, an antineoplastic agent, treats various cancers including breast, non-small cell lung, pancreatic, renal, hematologic malignancies, multiple myeloma, lymphomas, and bone cancers. Administered intravenously under medical supervision, dosage and frequency are determined by the treating physician based on individual needs and may vary. Strict adherence to the prescribed regimen is crucial; improper use or overdose can lead to severe adverse events. Therapeutic effects may not be immediately apparent, potentially requiring weeks or months; discontinuation should only occur under medical guidance. Common side effects include alopecia, peripheral paresthesia (numbness and tingling in extremities), and bowel irregularity. The drug can suppress white blood cell counts, increasing infection risk, and may in some instances induce uric acid-related nephropathy. Regular blood tests monitoring blood cell counts, cardiac, hepatic, and uric acid levels are necessary. Inform your physician of all concurrent medications, as interactions are possible. This medication is contraindicated during pregnancy and lactation; effective contraception is essential for both partners throughout treatment. Avoid direct ocular contact to prevent eye irritation.
Primary Ingredients of Vincrinak 2mg Injection
No information provided. Please provide the text you wish me to rephrase.
Uses of Vincrinak 2mg Injection
Cancers affecting the breast, lungs (non-small cell), pancreas, kidneys, blood (including multiple myeloma), lymphatic system, and bones.
Major Benefits of Vincrinak 2mg Injection:
This medication will be administered by your physician or their qualified assistant; self-medication is strictly prohibited.
Common Side effects of Vincrinak 2mg Injection:
- Hair loss
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Constipation
How to use Vincrinak 2mg Injection:
This medication will be administered by your healthcare provider; please do not attempt self-medication.
How Vincrinak 2mg Injection works:
Vincrinak 2mg Injection halts cancer cell proliferation by inhibiting DNA replication, thereby preventing further tumor growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Vincrinak 2mg Injection may pose unknown risks. Physician consultation is advised.
PregnancyCONSULT YOUR DOCTOR
Administering Vincrinak 2mg Injection during pregnancy is contraindicated due to established fetal risks. In exceptional, life-threatening circumstances, a physician might consider its use if the potential benefits outweigh the known hazards. Physician consultation is mandatory.
Breast feedingUNSAFE
Breastfeeding mothers should not use Vincrinak 2mg Injection. Evidence indicates potential infant toxicity from this medication.
DrivingUNSAFE
Administering Vincrinak 2mg Injection might result in adverse reactions that could impair driving capabilities.
KidneyCAUTION
Patients with kidney impairment should use Vincrinak 2mg Injection cautiously, potentially requiring a modified dosage. Physician consultation is advised.
LiverCAUTION
For individuals with hepatic impairment, administration of Vincrinak 2mg Injection requires careful monitoring. Dosage modification of Vincrinak 2mg Injection may be necessary. Physician consultation is advised.
What if you forget to take Vincrinak 2mg Injection :
NA
Facts to Know About Vincrinak 2mg Injection
| Label | Value |
|---|---|
| Chemical Category | Vinca-derived anticancer agents |
| Developing Habits | No. |
| Type of Therapy | Cancer Medications |
| Behavior Class | Vinca Alkaloid Antimicrotubule Agents |
3,018 People bought this recently